Posttranslational modifications of collagens as targets of hypoxia and Hif-1alpha in endochondral bone development.
In recent years, it has been proposed that oxygen is not only an indispensable metabolic substrate, but also a regulatory signal, and that gradients of oxygenation turn on a specific genetic program. A crucial mediator of the adaptive response of cells to hypoxia is the transcription factor hypoxia-inducible factor 1alpha (Hif-1alpha). The fetal growth plate, which is an avascular structure of mesenchymal origin, has a unique out-in gradient of oxygenation. Hif-1alpha is required for chondrogenesis in vivo by controlling a complex homeostatic response that allows chondrocytes to survive and differentiate in an hypoxic environment. Preliminary evidence suggests that regulation of posttranslational modifications of collagens could be an important component of this adaptive response.
Schipani
Ernestina
E
MGH-Harvard Medical School, Boston, Massachusetts, USA. schipani@helix.mgh.harvard.edu
D000818:Animals; D001846:Bone Development / Q000502:physiology*; D015687:Cell Hypoxia / Q000502:physiology; D002470:Cell Survival / Q000502:physiology; D019902:Chondrocytes / Q000378:metabolism / Q000502:physiology; D020219:Chondrogenesis / Q000502:physiology*; D003094:Collagen / Q000378:metabolism*; D006132:Growth Plate / Q000196:embryology / Q000378:metabolism; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism / Q000502:physiology*; D011499:Protein Processing, Post-Translational
D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D003094:Collagen
Genes Dev. 2004 Sep 15;18(18):2183-94
15371333
J Cell Biol. 2007 May 7;177(3):451-64
17470636
Obstet Gynecol. 1992 Aug;80(2):283-5
1635745
J Biol Chem. 2003 Aug 15;278(33):30772-80
12788921
Birth Defects Res C Embryo Today. 2005 Sep;75(3):200-12
16187326
Genes Dev. 1998 Jan 15;12(2):149-62
9436976
Nature. 2003 May 15;423(6937):316-8
12748648
J Neurosci. 2000 Oct 1;20(19):7370-6
11007895
Cancer Biol Ther. 2004 Jun;3(6):492-7
15254394
Cell Cycle. 2008 May 1;7(9):1128-32
18418042
Semin Radiat Oncol. 2004 Jul;14(3):207-14
15254863
J Neurosci. 2000 Oct 1;20(19):7377-83
11007896
Development. 2007 Nov;134(21):3917-28
17913788
J Biol Chem. 2004 Sep 17;279(38):40007-16
15263007
Nature. 2006 May 25;441(7092):437-43
16724055
Nat Rev Cancer. 2003 Oct;3(10):721-32
13130303
Ann N Y Acad Sci. 1996 Jun 8;785:124-30
8702118
Genes Dev. 2002 Jun 15;16(12):1441-5
12080083
Dev Cell. 2002 Mar;2(3):331-41
11879638
Mol Cell Biol. 2005 Apr;25(8):3040-55
15798192
Am J Pathol. 2006 Aug;169(2):491-502
16877351
EMBO J. 1998 Jun 1;17(11):3005-15
9606183
Nat Rev Drug Discov. 2003 Oct;2(10):803-11
14526383
Cancer Cell. 2009 Jan 6;15(1):35-44
19111879
Nat Rev Mol Cell Biol. 2008 Apr;9(4):285-96
18285802
Bone. 2005 Sep;37(3):313-22
16023419
PLoS Biol. 2007 Mar;5(3):e44
17298185
Genes Dev. 2001 Nov 1;15(21):2865-76
11691837
J Biol Chem. 2006 Oct 13;281(41):30678-83
16926163
PLoS Biol. 2004 Oct;2(10):e289
15361934
Dev Cell. 2005 Nov;9(5):617-28
16256737
J Pathol. 2005 Jul;206(3):291-304
15906272
Trends Mol Med. 2006 Apr;12(4):141-3
16513423
Mol Cell Biol. 2005 Dec;25(23):10479-91
16287860
Cardiovasc Res. 2003 Dec 1;60(3):569-79
14659802
J Biol Chem. 2007 May 4;282(18):13672-9
17360716
Teratology. 1999 Oct;60(4):215-25
10508975
Glycobiology. 2002 Apr;12(4):57R-68R
12042245
Genes Dev. 2008 Oct 15;22(20):2750-4
18923073
Pediatr Endocrinol Rev. 2003 Sep;1(1):2-8
16437008